What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Internal medicine
- Bacteria
Microbiology, Vancomycin, Staphylococcus aureus, Staphylococcal infections and Methicillin-resistant Staphylococcus aureus are his primary areas of study.
His research investigates the connection between Microbiology and topics such as Virulence that intersect with issues in Clade and Clone.
His Vancomycin study combines topics from a wide range of disciplines, such as Bacteremia, Internal medicine and Molecular epidemiology.
The Micrococcaceae research Benjamin P. Howden does as part of his general Staphylococcus aureus study is frequently linked to other disciplines of science, such as Cell wall thickening, therefore creating a link between diverse domains of science.
His biological study spans a wide range of topics, including Rifampicin, Mutation, Immunology, Fusidic acid and rpoB.
While the research belongs to areas of Methicillin-resistant Staphylococcus aureus, Benjamin P. Howden spends his time largely on the problem of Epidemiology, intersecting his research to questions surrounding Pneumonia and Standard treatment.
His most cited work include:
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications (656 citations)
- Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility (442 citations)
- Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (343 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Microbiology, Staphylococcus aureus, Antibiotic resistance, Drug resistance and Internal medicine.
His Microbiology study integrates concerns from other disciplines, such as Vancomycin, Methicillin-resistant Staphylococcus aureus and Virulence.
Vancomycin connects with themes related to Virology in his study.
He works mostly in the field of Staphylococcus aureus, limiting it down to topics relating to Antibiotics and, in certain cases, Intensive care medicine.
His Antibiotic resistance research integrates issues from Human pathogen, Multiple drug resistance and rpoB.
His Internal medicine research includes themes of Bacteremia, Flucloxacillin and Surgery.
He most often published in these fields:
- Microbiology (40.56%)
- Staphylococcus aureus (28.17%)
- Antibiotic resistance (26.63%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (19.20%)
- Severe acute respiratory syndrome coronavirus 2 (4.95%)
- Microbiology (40.56%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Severe acute respiratory syndrome coronavirus 2, Microbiology, Antibiotic resistance and Public health.
His Internal medicine study combines topics in areas such as Clinical microbiology and Typing.
His research integrates issues of Chronic infection, Outbreak and Staphylococcus aureus in his study of Microbiology.
His primary area of study in Staphylococcus aureus is in the field of Staphylococcal infections.
His work is dedicated to discovering how Antibiotic resistance, Multiple drug resistance are connected with Shigella sonnei, Fusidic acid, Skin infection, Mupirocin and Tetracycline and other disciplines.
His Public health study also includes
- MEDLINE which intersects with area such as Antigen testing, Molecular epidemiology and Quartile,
- Point of care which connect with Family medicine,
- Genomics and Incidence most often made with reference to Environmental health.
Between 2019 and 2021, his most popular works were:
- Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. (143 citations)
- Tracking the COVID-19 pandemic in Australia using genomics. (57 citations)
- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial (48 citations)
In his most recent research, the most cited papers focused on:
- Antibiotics
- Bacteria
- Internal medicine
Benjamin P. Howden focuses on Severe acute respiratory syndrome coronavirus 2, Internal medicine, Pandemic, Point-of-care testing and Serology.
As part of his studies on Internal medicine, he often connects relevant areas like Flucloxacillin.
His Pandemic investigation overlaps with other disciplines such as Environmental health, Genomics, Public health and Virology.
His work on Transmission as part of general Virology study is frequently linked to Candida auris, therefore connecting diverse disciplines of science.
His Randomized controlled trial research is multidisciplinary, relying on both Bacteremia, Pharmacotherapy, Methicillin-resistant Staphylococcus aureus and Combination therapy.
The concepts of his Combination therapy study are interwoven with issues in Vancomycin and Hemodialysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
